Sana Biotechnology Inc (SANA) stock: 12-month forecast projects 282.78% potential return%

Sana Biotechnology Inc [SANA] stock is trading at $2.09, up 24.40%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SANA shares have gain 16.43% over the last week, with a monthly amount glided 31.45%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on March 18, 2025, when Citizens JMP upgraded its rating to a Mkt Outperform but kept the price target unchanged to $5 for it. Previously, Jefferies started tracking the stock with Buy rating on March 14, 2025, and set its price target to $7. On January 08, 2025, upgrade upgraded it’s rating to Buy. JMP Securities downgraded its rating to a Mkt Perform. Rodman & Renshaw initiated its recommendation with a Buy and recommended $16 as its price target on June 26, 2024. H.C. Wainwright upgraded its rating to Buy for this stock on January 16, 2024, but kept the price target unchanged to $12. In a note dated September 25, 2023, JMP Securities initiated an Mkt Outperform rating and provided a target price of $9 on this stock.

Sana Biotechnology Inc [SANA] stock has fluctuated between $1.26 and $9.02 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $2.09 at the most recent close of the market. An investor can expect a potential return of 282.78% based on the average SANA price forecast.

Analyzing the SANA fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -0.76 and Total Capital is -0.52. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.44.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

For context, Sana Biotechnology Inc’s Current Ratio is 3.40. Also, the Quick Ratio is 3.40, while the Cash Ratio stands at 2.9.

Transactions by insiders

Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Feb 18 ’25 when 75000.0 shares were purchased. Officer, CHRISTIAN HORDO & KATHARINE HO completed a deal on Jan 16 ’25 to buy 75000.0 shares. Meanwhile, See Remark 1 FMR LLC sold 0.29 million shares on Jan 08 ’25.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.